Compare Cart
Cover Image
Market Research Report
Product code 
1018028

Europe Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product ; Functionality ; Type of Formulation
Published: | The Insight Partners | 167 Pages | Delivery time: 1-2 business days

Price

Back to Top
Europe Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product ; Functionality ; Type of Formulation
Published: June 4, 2021
The Insight Partners
Content info: 167 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The pharmaceutical excipients market in Europe is expected to grow from US$ 2,560.5 million in 2019 to US$ 3,796.4 million by 2027; it is estimated to grow at a CAGR of 5.8% 2020-2027. Nano delivery systems and nanomedicine are new and yet rapidly growing fields where nanoscale materials are used to deliver therapeutic agents to specific targeted sites or are used as diagnostic tools. Nanotechnology provides several advantages in the treatment of chronic human diseases by site-specific and selective delivery of accurate medicines. Application of nanotechnology for the prevention and treatment of diseases has created a broader forum for the distribution of 'difficult to deliver active pharmaceutical ingredients. This increased use of nanotechnology-assisted drug delivery systems (NADDS) has shown wide-range of benefits from enhancing oral bioavailability to targeting of drugs to tissues. NADDS face challenges in their production and manufacture. Many excipients are used to prevent aggregation during processing and to achieve nanoscale size. Excipients are traditionally used to promote the conversion of APIs into medicinal products, as they contribute to processing, product stability and efficiency. In view of the diversity of NADDS, such systems need a complex three-dimensional structure for their operation. In addition, excipients also play a key role in increasing absorption or successful targeting. Consequently, the efficient production of NADDS includes a detailed understanding of the physicochemical properties and functionality of the excipients. Thus, the excipients enabling nanotechnology are likely to witness intensive scientific investigations, as they have the capability to contribute unique functionality to the drug products.

The market for pharmaceutical excipients market is segmented into product, functionality, and type of formulation. Based on product, the pharmaceutical excipients market is segmented into organic chemicals, inorganic chemicals, and other products. In 2019, the organic chemicals segment accounted for the largest share, and is expected to grow at a fastest CAGR during the forecast period. Organic chemicals are chemical compounds that contain carbon-hydrogen bonds, and these can be found in natural or synthetic form. Most organic chemicals are carbon based, hence produced by plants or animals, whereas synthetic organic chemicals are produced through chemical reactions. Organically derived pharmaceuticals excipients include oleochemicals, carbohydrates, petrochemicals, proteins, povidones, acrylic polymers, mineral hydrocarbons, starch, cellulose, and others. The most used oleo chemical-based pharmaceutical excipients are fatty alcohols, mineral stearates, glycerin, and lipids. The organic segment is expected to lead the market owing to the rise in the use of organic chemicals in various formulations in the pharmaceutical industry.

Critical drugs can be added to the list in due course as further clinical policies are developed to support the COVID-19 response. Likely, any medicine containing a new active substance for the treatment of viral diseases falls within the mandatory scope of the centralized procedure, meaning that they must be assessed by the European Medicines Agency (EMA) and authorized by the European Commission. EMA is ready to support medicine developers with all available regulatory tools to advance and expedite the development of effective measures to fight and prevent the spread of this virus. These include fast tracked scientific advice, PRIME scheme, accelerated assessments and conditional marketing authorizations. Further, growing research activities to develop treatment against corona virus is likely to favor the growth of the market. As Europe has been impacted by the COVID-19 pandemic, an extensive clinical research is currently being conducted to identify effective therapies. The UK dominates the COVID-19 research space, and accounts for the largest number of clinical trials (24.5%), which is then followed by Spain (13.2%), France (9.5%), Italy (5.3%), Russia (4.8%), and Germany (3.8%).

The overall Europe pharmaceutical excipients market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining overview and forecast for the Europe pharmaceutical excipients market with respects to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants who typically take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the Europe pharmaceutical excipients market. DuPont de Nemours, Inc.; Roquette Freres; Ashland Global Holdings, Inc.; BASF SE; Evonik Industries AG; Associated British Foods Plc; Archer Daniels Midland Company; Lubrizol Corporation; DFE Pharma; and Croda International Plc are among a few players operating in the Europe pharmaceutical excipients market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe pharmaceutical excipients market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe pharmaceutical excipients market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the pharmaceutical excipients market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Product Code: TIPRE00022813

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Pharmaceutical Excipients Market - By Product
    • 1.3.2 Pharmaceutical Excipients Market - By Functionality
    • 1.3.3 Pharmaceutical Excipients Market - By Type of Formulation
    • 1.3.4 Europe Pharmaceutical Excipients Market - By Country

2. Europe Pharmaceutical Excipients Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Pharmaceutical Excipients Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Pharmaceutical Excipients Market- Europe PEST Analysis
  • 4.3 Expert Opinion

5. Europe Pharmaceutical Excipients Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Surge In Generics Market
    • 5.1.2 Growth of the Pharmaceutical Market Backed By Multi-Functional Excipients
  • 5.2 Market Restraints
    • 5.2.1 Cost and Time Intensive Drug Development Process
  • 5.3 Future Trends
    • 5.3.1 Rising Demand and Emphasis on Co-Processed Excipients
    • 5.3.2 Improving Excipient Capabilities due to Nanotechnology
  • 5.4 Impact Analysis

6. Pharmaceutical Excipients Market - Europe Analysis

  • 6.1 Europe Pharmaceutical Excipients Market Revenue Forecasts and Analysis

7. Europe Pharmaceutical Excipients Market Analysis and Forecasts To 2027 - By Product

  • 7.1 Overview
  • 7.2 Pharmaceutical Excipients Market Share, by Product, 2019 and 2027 (%)
  • 7.3 Organic Chemicals
    • 7.3.1 Overview
    • 7.3.2 Organic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 7.4 Inorganic Chemicals
    • 7.4.1 Overview
    • 7.4.2 Inorganic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 7.5 Other Products
    • 7.5.1 Overview
    • 7.5.2 Other Products: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)

8. Europe Pharmaceutical Excipients Market Analysis and Forecasts To 2027 - By Functionality

  • 8.1 Overview
  • 8.2 Pharmaceutical Excipients Market Share, by Functionality, 2019 and 2027 (%)
  • 8.3 Fillers And Diluents
    • 8.3.1 Overview
    • 8.3.2 Fillers and Diluents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.4 Suspending And Viscosity Agents
    • 8.4.1 Overview
    • 8.4.2 Suspending and Viscosity Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.5 Coating Agents
    • 8.5.1 Overview
    • 8.5.2 Coating Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.6 Binders
    • 8.6.1 Overview
    • 8.6.2 Binders: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.7 Preservatives
    • 8.7.1 Overview
    • 8.7.2 Preservatives: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.8 Emulsifying Agents
    • 8.8.1 Overview
    • 8.8.2 Emulsifying Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.9 Other Functionalities
    • 8.9.1 Overview
    • 8.9.2 Other Functionalities: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)

9. Europe Pharmaceutical Excipients Market Analysis and Forecasts to 2027- By Type of Formulation

  • 9.1 Overview
  • 9.2 Pharmaceutical Excipients Market Share, by Type of Formulation, 2019 and 2027 (%)
  • 9.3 Oral Formulations
    • 9.3.1 Overview
    • 9.3.2 Oral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 9.4 Topical Formulations
    • 9.4.1 Overview
    • 9.4.2 Topical Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 9.5 Parenteral Formulations
    • 9.5.1 Overview
    • 9.5.2 Parenteral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 9.6 Other Formulations
    • 9.6.1 Overview
    • 9.6.2 Other Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)

10. Pharmaceutical Excipients Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 10.1 Europe: Pharmaceutical Excipients Market
    • 10.1.1 Overview
    • 10.1.2 Europe: Pharmaceutical Excipients Market, by Country, 2019 & 2027 (%)
    • 10.1.3 Germany: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.1 Germany: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.2 Germany: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
      • 10.1.3.3 Germany: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
      • 10.1.3.4 Germany: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD million)
    • 10.1.4 UK: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.4.1 UK Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.4.2 UK: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
      • 10.1.4.3 UK: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
      • 10.1.4.4 UK: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD million)
    • 10.1.5 France: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.5.1 France: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.5.2 France: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
      • 10.1.5.3 France: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
      • 10.1.5.4 France: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD million)
    • 10.1.6 Spain: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.6.1 Spain: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.6.2 Spain: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
      • 10.1.6.3 Spain: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
      • 10.1.6.4 Spain: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD million)
    • 10.1.7 Italy: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 Italy: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 Italy: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
      • 10.1.7.3 Italy: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
      • 10.1.7.4 Italy: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD million)

11. Impact Of COVID-19 Pandemic on Europe Pharmaceutical Excipients Market

  • 11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. COMPANY PROFILES

  • 13.1 DuPont de Nemours, Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Roquette Freres
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Ashland Global Holdings Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 BASF SE
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Evonik
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Associated British Foods plc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Archer Daniels Midland Company
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Lubrizol Corporation
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 DFE Pharma
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Croda International plc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Germany Pharmaceutical Excipients Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 2. Germany Pharmaceutical Excipients Market, by Functionality - Revenue and Forecast to 2027 (USD Million)
  • Table 3. Germany Pharmaceutical Excipients Market, by Type of Formulation - Revenue and Forecast to 2027 (USD Million)
  • Table 4. UK Pharmaceutical Excipients Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 5. UK Pharmaceutical Excipients Market, by Functionality - Revenue and Forecast to 2027 (USD Million)
  • Table 6. UK Pharmaceutical Excipients Market, by Type of Formulation - Revenue and Forecast to 2027 (USD Million)
  • Table 7. France Pharmaceutical Excipients Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 8. France Pharmaceutical Excipients Market, by Functionality - Revenue and Forecast to 2027 (USD Million)
  • Table 9. France Pharmaceutical Excipients Market, by Type of Formulation - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Spain Pharmaceutical Excipients Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Spain Pharmaceutical Excipients Market, by Functionality - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Spain Pharmaceutical Excipients Market, by Type of Formulation - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Italy Pharmaceutical Excipients Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Italy Pharmaceutical Excipients Market, by Functionality - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Italy Pharmaceutical Excipients Market, by Type of Formulation - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Organic Developments Done By Companies
  • Table 17. Inorganic Developments Done By Companies
  • Table 18. Glossary of Terms, Pharmaceutical Excipients Market

List Of Figures

  • Figure 1. Pharmaceutical Excipients Market Segmentation
  • Figure 2. Europe Pharmaceutical Excipients Market Overview
  • Figure 3. Organic Chemicals Segment Held Largest Share of Product in Pharmaceutical Excipients Market
  • Figure 4. Oral Formulations Segment Held Largest Share of Type of Formulation in Pharmaceutical Excipients Market
  • Figure 5. UK is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Pharmaceutical Excipients Market - Europe PEST Analysis
  • Figure 7. Pharmaceutical Excipients Market Impact Analysis of Driver and Restraints
  • Figure 8. Europe Pharmaceutical Excipients Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 9. Pharmaceutical Excipients Market Share, by Product, 2019 and 2027 (%)
  • Figure 10. Organic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 11. Inorganic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 12. Other Products: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 13. Pharmaceutical Excipients Market Share, by Functionality, 2019 and 2027 (%)
  • Figure 14. Fillers and Diluents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 15. Suspending and Viscosity Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 16. Coating Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 17. Binders: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 18. Preservatives: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 19. Emulsifying Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 20. Other Functionalities: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 21. Pharmaceutical Excipients Market Share, by Type of Formulation, 2019 and 2027 (%)
  • Figure 22. Oral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 23. Topical Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 24. Parenteral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 25. Other Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 26. Europe: Pharmaceutical Excipients Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 27. Europe: Pharmaceutical Excipients Market, by Country, 2019 & 2027 (%)
  • Figure 28. Germany: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 29. UK: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. France: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 31. Spain: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 32. Italy: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 33. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 34. Growth Strategies Done by the Companies in the Market, (%)